<i>LPA</i> Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

Wei‐Qi Wei(Vanderbilt University Medical Center), Joshua C. Denny(National Institutes of Health), Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), Todd L. Edwards(Nashville VA Medical Center), Jennifer A. Pacheco(University of Arizona), Marc S. Williams(Geisinger Health System), David R. Crosslin(Tulane University), QiPing Feng(Vanderbilt University Medical Center), Eric Larson(University of South Dakota), Nancy J. Cox(Vanderbilt University Medical Center), Jerome I. Rotter(Harbor–UCLA Medical Center), Ning Shang(St. Jude Children's Research Hospital), Laura J. Rasmussen‐Torvik(Northwestern University), George Hripcsak(Columbia University), David Cronkite(Kaiser Permanente Washington Health Research Institute), Dan M. Roden(Garvan Institute of Medical Research), Gail P. Jarvik(University of Washington Medical Center), Iftikhar J. Kullo(Medical College of Wisconsin), Harris T. Bland(Vanderbilt University Medical Center), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Ronald M. Krauss(University of California System), Marylyn D. Ritchie(Medical University of South Carolina), Elizabeth W. Karlson(Brigham and Women's Hospital), Ming Ta Michael Lee(Institute of Biomedical Sciences, Academia Sinica), Peggy Peissig(Pew Research Center), Xiaohui Li(Cedars-Sinai Medical Center), Eric B. Larson(University of Washington), Jonathan D. Mosley(Tennessee Department of Health), Shiro Maeda(Shiga University of Medical Science), Russell A. Wilke(Vanderbilt University Medical Center), Momoko Horikoshi(RIKEN Center for Integrative Medical Sciences), Christian M. Shaffer(Vanderbilt University Medical Center), Christoph Stein(Charité - Universitätsmedizin Berlin)
Circulation
April 27, 2018
Cited by 92


Related Papers